Single-cell RNA Sequencing analysis of PBMCs from patients treated with AZD4573 on a clinical trial demonstrated sustained downregulation of MYC targets and OxPhos in malignant B-cells from a responding patient with MCL. This evidence concerns the gene MYC and mantle cell lymphoma.